Literature DB >> 11600383

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins.

J M Guthmiller1, K G Vargas, R Srikantha, L L Schomberg, P L Weistroffer, P B McCray, B F Tack.   

Abstract

The effects of cathelicidins against oral bacteria and clinically important oral yeasts are not known. We tested the susceptibilities of Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis, Streptococcus sanguis, Candida krusei, Candida tropicalis and Candida albicans to the following cathelicidins: FALL39, SMAP29, and CAP18. SMAP29 and CAP18 were antimicrobial, whereas FALL39 did not exhibit antimicrobial activity. Future studies are needed to determine the potential use of these antimicrobial peptides in prevention and treatment of oral infections.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11600383      PMCID： PMC90809          DOI： 10.1128/AAC.45.11.3216-3219.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Molecular basis of Candida albicans adhesion.

Authors:  M J Kennedy; R A Calderone; J E Cutler; T Kanabe; M H Riesselman; R Robert; J M Senet; V Annaix; A Bouali; C Mahaza
Journal:  J Med Vet Mycol       Date:  1992

Review 2.  Crevicular fluid: origin, composition, methods of collection, and clinical significance.

Authors:  B H Abbott; R G Caffesse
Journal:  J West Soc Periodontol Periodontal Abstr       Date:  1977

Review 3.  Host response tests for diagnosing periodontal diseases.

Authors:  R C Page
Journal:  J Periodontol       Date:  1992-04       Impact factor: 6.993

Review 4.  Structural features of salivary function.

Authors:  M S Lamkin; F G Oppenheim
Journal:  Crit Rev Oral Biol Med       Date:  1993

5.  In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.

Authors:  K T Miyasaki; A L Bodeau; T Ganz; M E Selsted; R I Lehrer
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  Bactericidal activity of mammalian cathelicidin-derived peptides.

Authors:  S M Travis; N N Anderson; W R Forsyth; C Espiritu; B D Conway; E P Greenberg; P B McCray; R I Lehrer; M J Welsh; B F Tack
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

Authors:  S L Newman; T P Flanigan; A Fisher; M G Rinaldi; M Stein; K Vigilante
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

8.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; A Foreman; C Shu; K Zarember; O Levy; P Elsbach; J Weiss
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

Authors:  D Law; C B Moore; H M Wardle; L A Ganguli; M G Keaney; D W Denning
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

10.  Rabbit CAP18 derived peptides inhibit gram negative and gram positive bacteria.

Authors:  J W Larrick; M Hirata; Y Shimomoura; M Yoshida; H Zheng; J Zhong; S C Wright
Journal:  Prog Clin Biol Res       Date:  1994
View more
  13 in total

1.  Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue.

Authors:  I Hosokawa; Y Hosokawa; H Komatsuzawa; R B Goncalves; N Karimbux; M H Napimoga; M Seki; K Ouhara; M Sugai; M A Taubman; T Kawai
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

2.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Promise of Combining Antifungal Agents in Denture Adhesives to Fight Candida Species Infections.

Authors:  Jorge L Garaicoa; Carol L Fischer; Amber M Bates; Julie Holloway; Gustavo Avila-Ortiz; Janet M Guthmiller; Georgia K Johnson; Clark Stanford; Kim A Brogden
Journal:  J Prosthodont       Date:  2016-11-21       Impact factor: 2.752

Review 5.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria.

Authors:  M Puklo; A Guentsch; P S Hiemstra; S Eick; J Potempa
Journal:  Oral Microbiol Immunol       Date:  2008-08

7.  Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.

Authors:  Sophie Joly; Connie Maze; Paul B McCray; Janet M Guthmiller
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture.

Authors:  Michael R Franzman; Kindra K Burnell; Farideh H Dehkordi-Vakil; Janet M Guthmiller; Deborah V Dawson; Kim A Brogden
Journal:  Int J Antimicrob Agents       Date:  2008-09-07       Impact factor: 5.283

9.  Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent.

Authors:  Gilad Bachrach; Hamutal Altman; Paul E Kolenbrander; Natalia I Chalmers; Michal Gabai-Gutner; Amram Mor; Michael Friedman; Doron Steinberg
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

Review 10.  Antimicrobial peptides in the oral environment: expression and function in health and disease.

Authors:  Beverly A Dale; L Page Fredericks
Journal:  Curr Issues Mol Biol       Date:  2005-07       Impact factor: 2.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.